IP Library › Assignment 061607/0534
Patent Assignment
Reel/Frame 061607/0534

Assignment of Assignor's Interest

Recorded: 2022-11-01 Pages: 8
Assignors
FLOHR, ALEXANDER
Executed: 2022-10-07
ARISTA, LUCA
Executed: 2022-10-06
OTTAVIANI, GIORGIO
Executed: 2022-10-16
Assignee
RIDGELINE THERAPEUTICS GMBH
TECHNOLOGIEPARK, HOCHBERGERSTRASSE 60C CH, BASEL, 02142, SWITZERLAND
Covered Properties (6)
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application: 63/108,645 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application: 63/166,045 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application: 63/190,067 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application: 63/218,717 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Application: 63/237,782 →
Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 1, 2022
From: RIDGELINE THERAPEUTICS GMBH
To: BLACK DIAMOND THERAPEUTICS
Reel/Frame 061607/0567 →
Assignment of Assignor's Interest Nov 1, 2022
From: BUCK, ELIZABETH; O'CONNOR, MATTHEW; ROMASHKO, DARLENE; LIN, TAI-AN
To: BLACK DIAMOND THERAPEUTICS
Reel/Frame 061607/0519 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 061607 Frame: 0519. Assignor(S) Hereby Confirms the Assignment. Sep 6, 2023
From: BUCK, ELIZABETH; O'CONNOR, MATTHEW; ROMASHKO, DARLENE; LIN, TAI-AN
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 064819/0168 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 061607 Frame 0567. Assignor(S) Hereby Confirms the Assignment. Sep 6, 2023
From: RIDGELINE THERAPEUTICS GMBH
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 064819/0223 →
Assignment of Assignor's Interest Apr 8, 2025
From: EPSTEIN, DAVID M.
To: BLACK DIAMOND THERAPEUTICS, INC.
Reel/Frame 070772/0793 →